No Data
Jingtai Holdings-P (02228.HK) has reached a Global Strategy cooperation agreement with the China Small and Medium Enterprises Development Promotion Center under the Ministry of Industry and Information Technology.
On March 26, Glonghui reported that Crystal Technology Holdings-P (02228.HK) announced that Shenzhen Crystal Technology Co., Ltd. ("Crystal Technology", a wholly-owned subsidiary of the company) recently signed a Global Strategy cooperation agreement ("this cooperation") with the Small and Medium Enterprises Development Promotion Center of the Ministry of Industry and Information Technology ("the Center"). According to this cooperation, both parties will work together to implement the "AI+" initiative, drive continuous innovation through cutting-edge Technology, integrate common technologies to meet industrial landing needs, promote the deep integration of AI and Siasun Robot&Automation technology with traditional industries, jointly cultivate future industries, and accelerate the development of China's economy.
Express News | Xtalpi Holdings - Under Agreement Both Parties Will Cooperate to Implement Artificial Intelligent Initiative
Express News | Xtalpi - Unit and SME Development Promotion Center of Ministry of Industry and Information Technology Signed Strategic Cooperation Deal
Fangda Carbon New Material plans to invest 1 billion over three years to jointly develop a new generation of carbon-based materials with Jingtai Holdings-P (02228).
Both parties will take AI as the core driving force to carry out deep collaborative innovation in the field of New Materials, promoting the research and development of high-end carbon-based materials and upgrading Intelligent Manufacturing, injecting strong momentum for the implementation of China’s "AI +" national Global Strategy and the construction of new industrialization.
A significant partnership worth over 0.2 billion RMB has been established, opening the door for Crystal Technology Holdings-P (02228) to the trillion-dollar digital economy market in the Middle East.
Jingtai Holdings-P (02228) announced the formal signing of a commercial cooperation agreement with the office of Sheikh Hamad of the UAE royal family in Abu Dhabi to jointly build the first automated traditional medicine modernization research and development laboratory in the Middle East, with an initial investment of up to 30 million USD, equivalent to 0.22 billion yuan.
A strong alliance is advancing AI humanoid robots to empower cell therapy. Crystal Technology Holdings-P (02228), Leimon Biotech, and Yuejiang (02432) are opening a new era of precision medical care.
Recently, Hong Kong stock 18C AI leading company JingTai Holdings-P (02228) and its incubated cellular therapy emerging company LaiMang Biotech will collaborate with Siasun Robot&Automation to establish a joint venture, jointly developing a cellular therapy manufacturing platform based on AI humanoid robots. This cooperation marks the entry of the cellular therapy field into a new stage of intelligence and automation, providing Global patients with more efficient and precise treatment solutions.
